HOME >> MEDICINE >> NEWS
New SSRI effective for the treatment of moderate-to-severe premature ejaculation

A selective serotonin reuptake inhibitor (SSRI) developed specifically for the treatment of premature ejaculation is safe and effective for men severely affected by the condition, according to an Article in this week's issue of The Lancet.

Premature ejaculation is the most common form of male sexual dysfunction, affecting 21-33% of men. Although the condition is highly undertreated, SSRIs, which were developed to treat depression and other psychiatric disorders, are being increasingly used as unlicensed treatments for premature ejaculation based on their side-effect of delayed ejaculation. However, these drugs can have drawbacks such as psychiatric problems, skin reactions, changes in bodyweight, and sexual side-effects like loss of libido.

In the study Jon Pryor (University of Minnesota, Minneapolis, MN, USA) and colleagues combined the results of two trials testing the effectiveness of dapoxetine, a short-acting SSRI developed specifically for the treatment of premature ejaculation. The analysis involved over 2600 men with moderate to severe premature ejaculation and their partners. Patients were randomly assigned to receive placebo (870), 30 mg dapoxetine (874), or 60 mg dapoxetine (870) and were instructed to take a dose 1-3 hours before sexual intercourse. On average, at the start of the study, the men ejaculated under a minute after penetration. The researchers found that after 12 weeks the time to ejaculation was 1.75 minutes for placebo, 2.78 minutes for 30 mg dapoxetine, and 3.32 minutes for 60 mg dapoxetine.

Dr Pryor adds: "Dapoxetine also improved patients' perceptions of control over ejaculation, satisfaction with sexual intercourse, and overall impression of change in condition. Partners benefited through improved satisfaction with sexual intercourse."

Common side-effects of the drug were nausea, diarrhoea, headache and dizziness.


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
7-Sep-2006


Page: 1

Related medicine news :

1. New treatment effective in counteracting cocaine-induced symptoms
2. Osteoporosis screening and treatment may be cost-effective for selected older men
3. Study shows radiofrequency ablation highly effective in treating kidney tumors
4. New study examines effectiveness of tailored health messages
5. Scaling up HIV prevention programs is cost effective
6. New study shows Rescue Remedy is an effective all-natural stress, anxiety reliever
7. U of M researchers assess effectiveness of computerized physician order entry system
8. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
9. Meningitis: effectiveness of preventive vaccination demonstrated
10. U-M study finds lymphoma drug effective over long term
11. Chemotherapy may enhance the effectiveness of brain tumor vaccines

Post Your Comments:
(Date:9/3/2015)... Fullerton, Calif. (PRWEB) , ... September 03, 2015 , ... ... in Fullerton, where innovative medicine is the norm not the exception. , St. Jude ... and the American Heart Association/American Stroke Association, making it one of only 10 hospitals ...
(Date:9/3/2015)... New York (PRWEB) , ... September 03, 2015 , ... ... Do”. William Mattar, Esq. believes this does not stop at any certain demographic ... captioning to its newly produced one-minute, thirty-, fifteen- and ten-second TV commercials. , The ...
(Date:9/3/2015)... TX (PRWEB) , ... September 03, 2015 , ... ... pre-conference workshops included in Patient Experience Conference 2016, to be held April 13-15 ... non-provider or vendor hosted event bringing together the collective voices of healthcare leaders, ...
(Date:9/3/2015)... ... September 03, 2015 , ... DriButts, a non-profit organization dedicated ... Product Development Group to manufacture a long-lasting reusable diaper for warm weather climates ... to bring 600 DriButts Diapers to rural areas of Haiti during a trip ...
(Date:9/3/2015)... ... ... Real Time Pain Relief (RTPR), makers of the popular rub-on pain ... an official endorsement deal with the company. Originally from New South Wales, Australia, Mason ... 15. He is an Australian bull riding champion, following in his uncles’ footsteps in ...
Breaking Medicine News(10 mins):Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3Health News:Law Firm Focused on “Helping People” Continues to Expand on Vision 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 3Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3
(Date:9/3/2015)... , Sept. 3, 2015 This Defibrillators are ... save millions of lives across globe. This report provides ... Kingdom of Saudi Arabia . Stakeholders for this ... government agencies and regulatory bodies. The Saudi ... two perspectives: by products and by end users. In ...
(Date:9/3/2015)... MENLO PARK, Calif. , Sept. 3, 2015 /PRNewswire/ ... medical device company that is providing innovative evidence-based solutions ... its management will be presenting at the Morgan Stanley ... New York City.  Nevro management is ... will be accessible via a live audio webcast, accessible ...
(Date:9/3/2015)... , Sept. 3, 2015  Ascendis ... clinical stage biotechnology company that applies its ... medical needs, today announced plans to present ... Wells Fargo Healthcare Conference in BostonDate: , ... , Bank of America Merrill Lynch Global ...
Breaking Medicine Technology:Saudi Arabia Defibrillators Market: & Advanced Life Support Defibrillators; End Users; Industry Analysis, Size, Volume, Growth, Trends and Forecast 2014 - 2020 2Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences 2
Cached News: